Literature DB >> 2115307

Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: evaluation of morbidity.

E Doehring-Schwerdtfeger1, I M Abdel-Rahim, Q Mohamed-Ali, M Elsheikh, J Schlake, R Kardorff, D Franke, C Kaiser, J H Ehrich.   

Abstract

Morbidity of Schistosoma mansoni infection was assessed in 536 infected Sudanese schoolchildren using an ultrasonographical staging system for periportal fibrosis of the liver. S. mansoni ova excretion in stools was mild in 28%, moderate in 58%, and severe in 14% of the patients. Grade 1 periportal fibrosis was found in 10.3% grade 2 in 23.1%, and grade 3 in 4.7% of S. mansoni-infected children. Girls and boys were equally affected. The distribution of periportal fibrosis compared to the age of patients was homogenous. There was no significant difference of the rate of periportal fibrosis in the 3 groups of intensity of infection. However, in the 204 patients who showed periportal fibrosis, there was a strong relation between severity of ultrasonographically detectable fibrosis with intensity of egg excretion. In 332 children, of which 73 had a heavy infection, no signs of periportal fibrosis were detected. Sudanese children show a variable susceptibility towards the development of S. mansoni-induced periportal fibrosis. High risk patients can be detected at a childhood stage by measuring the intensity of infection and investigating the liver by ultrasound.

Entities:  

Mesh:

Year:  1990        PMID: 2115307     DOI: 10.4269/ajtmh.1990.42.581

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  7 in total

Review 1.  Schistosomiasis. Infection versus disease and hypersensitivity versus immunity.

Authors:  A W Cheever
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

2.  Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene.

Authors:  A J Dessein; D Hillaire; N E Elwali; S Marquet; Q Mohamed-Ali; A Mirghani; S Henri; A A Abdelhameed; O K Saeed; M M Magzoub; L Abel
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

3.  High prevalence and morbidity of Schistosoma mansoni along the Albert Nile in Uganda.

Authors:  Emmanuel I Odongo-Aginya; Lorenz Grigull; Ulrich Schweigmann; Tom Loroni-Lakwo; Jochem H H Enrich; Bruno Gryseels; Ekkehard Doehring
Journal:  Afr Health Sci       Date:  2002-12       Impact factor: 0.927

Review 4.  Human schistosomiasis.

Authors:  Daniel G Colley; Amaya L Bustinduy; W Evan Secor; Charles H King
Journal:  Lancet       Date:  2014-04-01       Impact factor: 79.321

5.  High burden of Schistosoma mansoni infection in school-aged children in Marolambo District, Madagascar.

Authors:  Stephen A Spencer; James M St John Penney; Hannah J Russell; Anthony P Howe; Cortland Linder; Andriamahitsisambatra L D Rakotomampianina; Anjara M Nandimbiniaina; S Bertel Squire; J Russell Stothard; Amaya L Bustinduy; Alain M Rahetilahy
Journal:  Parasit Vectors       Date:  2017-06-24       Impact factor: 3.876

6.  Evaluation of schistosoma mansoni morbidity one year after praziquantel treatment in rhino cAMP and obongi in west nile, Uganda.

Authors:  E I Odongo-Aginya; T L Lakwo; Med Ekkehard Doehring
Journal:  Afr J Infect Dis       Date:  2010

7.  Cytokine and Chemokine Profile in Individuals with Different Degrees of Periportal Fibrosis due to Schistosoma mansoni Infection.

Authors:  Robson Da Paixão De Souza; Luciana Santos Cardoso; Giuseppe Tittoni Varela Lopes; Maria Cecília F Almeida; Ricardo Riccio Oliveira; Leda Maria Alcântara; Edgar M Carvalho; Maria Ilma Araujo
Journal:  J Parasitol Res       Date:  2012-12-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.